1.
Maria Winqvist, Per-Ola Andersson, Anna Asklid, Karin Karlsson, Claes Karlsson, Birgitta Lauri, Jeanette Lundin, Mattias Mattsson, Stefan Norin, Anna Sandstedt, Richard Rosenquist, Florentin Späth, Lotta Hansson, Anders Österborg, for the Swedish CLL Group. Long-term real-world results of ibrutinib therapy in patients with relapsed or refractory chronic lymphocytic leukemia: 30-month follow up of the Swedish compassionate use cohort. haematol [Internet]. 2019May1 [cited 2023Feb.8];104(5):e208-e210. Available from: https://haematologica.org/article/view/8910